

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.58010771 |
| 2 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.58986086 |
| 3 | DNA unwinding involved in DNA replication (GO:0006268) | 4.51250193 |
| 4 | ribosome assembly (GO:0042255) | 4.26718726 |
| 5 | establishment of integrated proviral latency (GO:0075713) | 4.25841365 |
| 6 | mitotic chromosome condensation (GO:0007076) | 4.16994357 |
| 7 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.10152023 |
| 8 | pore complex assembly (GO:0046931) | 4.04916632 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.95216332 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.95216332 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 3.95216332 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 3.95216332 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 3.95216332 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.95216332 |
| 15 | positive regulation of interferon-alpha production (GO:0032727) | 3.85009155 |
| 16 | protein localization to chromosome, centromeric region (GO:0071459) | 3.84958850 |
| 17 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.81189062 |
| 18 | establishment of viral latency (GO:0019043) | 3.76581019 |
| 19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.69112760 |
| 20 | regulation of interferon-alpha production (GO:0032647) | 3.66421919 |
| 21 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.64964384 |
| 22 | formation of translation preinitiation complex (GO:0001731) | 3.63158790 |
| 23 | regulation of translational fidelity (GO:0006450) | 3.62108700 |
| 24 | DNA strand elongation (GO:0022616) | 3.60777120 |
| 25 | regulation of translational termination (GO:0006449) | 3.59378020 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 3.53362287 |
| 27 | protein maturation by protein folding (GO:0022417) | 3.52801090 |
| 28 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.51705909 |
| 29 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.45446868 |
| 30 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.45446868 |
| 31 | actin nucleation (GO:0045010) | 3.40098439 |
| 32 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.29953107 |
| 33 | protein retention in ER lumen (GO:0006621) | 3.29399641 |
| 34 | cellular protein complex localization (GO:0034629) | 3.28048830 |
| 35 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.24202155 |
| 36 | macrophage activation involved in immune response (GO:0002281) | 3.13676586 |
| 37 | neutrophil activation involved in immune response (GO:0002283) | 3.13456772 |
| 38 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.13247571 |
| 39 | natural killer cell mediated immunity (GO:0002228) | 3.13247571 |
| 40 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.11074395 |
| 41 | protein localization to kinetochore (GO:0034501) | 3.07489145 |
| 42 | hepatocyte apoptotic process (GO:0097284) | 3.04434689 |
| 43 | COPI coating of Golgi vesicle (GO:0048205) | 3.04009417 |
| 44 | Golgi transport vesicle coating (GO:0048200) | 3.04009417 |
| 45 | protein complex localization (GO:0031503) | 3.02329310 |
| 46 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.01494255 |
| 47 | mitotic sister chromatid segregation (GO:0000070) | 3.01321048 |
| 48 | positive regulation of interferon-beta production (GO:0032728) | 2.99325484 |
| 49 | B cell mediated immunity (GO:0019724) | 2.96424328 |
| 50 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.95771136 |
| 51 | protein localization to endosome (GO:0036010) | 2.95201720 |
| 52 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.93920296 |
| 53 | nuclear envelope reassembly (GO:0031468) | 2.88045470 |
| 54 | mitotic nuclear envelope reassembly (GO:0007084) | 2.88045470 |
| 55 | nuclear envelope disassembly (GO:0051081) | 2.87868323 |
| 56 | membrane disassembly (GO:0030397) | 2.87868323 |
| 57 | IMP biosynthetic process (GO:0006188) | 2.87263804 |
| 58 | protein export from nucleus (GO:0006611) | 2.82898918 |
| 59 | DNA replication initiation (GO:0006270) | 2.81456014 |
| 60 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.81185485 |
| 61 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.81185485 |
| 62 | de novo protein folding (GO:0006458) | 2.81057460 |
| 63 | ribosome biogenesis (GO:0042254) | 2.80964670 |
| 64 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.80488478 |
| 65 | establishment of chromosome localization (GO:0051303) | 2.79191590 |
| 66 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.78603866 |
| 67 | response to peptidoglycan (GO:0032494) | 2.78353855 |
| 68 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.76730884 |
| 69 | sister chromatid segregation (GO:0000819) | 2.76688009 |
| 70 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.76509891 |
| 71 | de novo posttranslational protein folding (GO:0051084) | 2.75075161 |
| 72 | tRNA aminoacylation for protein translation (GO:0006418) | 2.74244988 |
| 73 | nuclear pore organization (GO:0006999) | 2.73363730 |
| 74 | metaphase plate congression (GO:0051310) | 2.72660825 |
| 75 | mitochondrial fusion (GO:0008053) | 2.71532156 |
| 76 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.70073624 |
| 77 | pinocytosis (GO:0006907) | 2.68122294 |
| 78 | telomere maintenance via recombination (GO:0000722) | 2.67387379 |
| 79 | tRNA aminoacylation (GO:0043039) | 2.64282555 |
| 80 | amino acid activation (GO:0043038) | 2.64282555 |
| 81 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.64060631 |
| 82 | IMP metabolic process (GO:0046040) | 2.63880971 |
| 83 | cellular response to zinc ion (GO:0071294) | 2.63507175 |
| 84 | proline biosynthetic process (GO:0006561) | 2.61905938 |
| 85 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.58971828 |
| 86 | nuclear envelope organization (GO:0006998) | 2.58833214 |
| 87 | negative regulation of lipid storage (GO:0010888) | 2.57527021 |
| 88 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.53955505 |
| 89 | mitotic recombination (GO:0006312) | 2.52999674 |
| 90 | respiratory burst (GO:0045730) | 2.52268809 |
| 91 | regulation of cholesterol storage (GO:0010885) | 2.52086607 |
| 92 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.51477777 |
| 93 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.50964200 |
| 94 | mitotic sister chromatid cohesion (GO:0007064) | 2.50728167 |
| 95 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.49907422 |
| 96 | vesicle coating (GO:0006901) | 2.48315885 |
| 97 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.48266487 |
| 98 | regulation of translational elongation (GO:0006448) | 2.48094351 |
| 99 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.48067177 |
| 100 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.48067177 |
| 101 | folic acid metabolic process (GO:0046655) | 2.47930959 |
| 102 | nuclear pore complex assembly (GO:0051292) | 2.47645955 |
| 103 | response to host immune response (GO:0052572) | 2.45239038 |
| 104 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.45239038 |
| 105 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.45141974 |
| 106 | negative regulation of ligase activity (GO:0051352) | 2.44926932 |
| 107 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.44926932 |
| 108 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.44803354 |
| 109 | pentose-phosphate shunt (GO:0006098) | 2.44719426 |
| 110 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.42586148 |
| 111 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.41361152 |
| 112 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.40664197 |
| 113 | cellular glucuronidation (GO:0052695) | 2.40148637 |
| 114 | mitochondrial DNA metabolic process (GO:0032042) | 2.39663908 |
| 115 | positive regulation of nuclease activity (GO:0032075) | 2.39377668 |
| 116 | T cell apoptotic process (GO:0070231) | 2.38657442 |
| 117 | reactive oxygen species biosynthetic process (GO:1903409) | 2.38341350 |
| 118 | DNA topological change (GO:0006265) | 2.38229296 |
| 119 | leukocyte mediated cytotoxicity (GO:0001909) | 2.37764240 |
| 120 | ER-nucleus signaling pathway (GO:0006984) | 2.37397920 |
| 121 | protein localization to microtubule (GO:0035372) | 2.37232729 |
| 122 | DNA duplex unwinding (GO:0032508) | 2.37216078 |
| 123 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.36757060 |
| 124 | cytokine secretion (GO:0050663) | 2.36286983 |
| 125 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.34463295 |
| 126 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.34372540 |
| 127 | histone H2B ubiquitination (GO:0033523) | 2.34158797 |
| 128 | heterochromatin organization (GO:0070828) | 2.33637999 |
| 129 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.33446171 |
| 130 | response to host (GO:0075136) | 2.31646986 |
| 131 | response to host defenses (GO:0052200) | 2.31646986 |
| 132 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.31646986 |
| 133 | regulation of interferon-beta production (GO:0032648) | 2.31518110 |
| 134 | dosage compensation (GO:0007549) | 2.30750429 |
| 135 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.30735848 |
| 136 | non-recombinational repair (GO:0000726) | 2.30735848 |
| 137 | cell adhesion mediated by integrin (GO:0033627) | 2.30231895 |
| 138 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.29594905 |
| 139 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.29045813 |
| 140 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.28435172 |
| 141 | histone arginine methylation (GO:0034969) | 2.27712617 |
| 142 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.27462568 |
| 143 | regulation of nuclease activity (GO:0032069) | 2.27198330 |
| 144 | regulation of mitotic spindle organization (GO:0060236) | 2.27181569 |
| 145 | mitotic metaphase plate congression (GO:0007080) | 2.27152529 |
| 146 | doxorubicin metabolic process (GO:0044598) | 2.26325958 |
| 147 | daunorubicin metabolic process (GO:0044597) | 2.26325958 |
| 148 | polyketide metabolic process (GO:0030638) | 2.26325958 |
| 149 | apoptotic cell clearance (GO:0043277) | 2.26239085 |
| 150 | peptidyl-arginine N-methylation (GO:0035246) | 2.26095572 |
| 151 | peptidyl-arginine methylation (GO:0018216) | 2.26095572 |
| 152 | signal peptide processing (GO:0006465) | 2.25426515 |
| 153 | protein carboxylation (GO:0018214) | 2.23952210 |
| 154 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.23952210 |
| 155 | plasma lipoprotein particle assembly (GO:0034377) | 2.21504742 |
| 156 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.21141256 |
| 157 | folic acid transport (GO:0015884) | 2.20070493 |
| 158 | cysteine metabolic process (GO:0006534) | 2.20047275 |
| 159 | phospholipid homeostasis (GO:0055091) | 2.18886383 |
| 160 | uronic acid metabolic process (GO:0006063) | 2.18005275 |
| 161 | glucuronate metabolic process (GO:0019585) | 2.18005275 |
| 162 | reverse cholesterol transport (GO:0043691) | 2.17791870 |
| 163 | response to interferon-alpha (GO:0035455) | 2.16495633 |
| 164 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.15670202 |
| 165 | glycine metabolic process (GO:0006544) | 2.13664845 |
| 166 | regulation of mast cell degranulation (GO:0043304) | 2.12915692 |
| 167 | response to fungus (GO:0009620) | 2.12318499 |
| 168 | histone-serine phosphorylation (GO:0035404) | 2.12102344 |
| 169 | macrophage activation (GO:0042116) | 2.12090962 |
| 170 | positive regulation of leukocyte degranulation (GO:0043302) | 2.11426131 |
| 171 | COPII vesicle coating (GO:0048208) | 2.11250999 |
| 172 | negative regulation of phagocytosis (GO:0050765) | 2.11150609 |
| 173 | phospholipid efflux (GO:0033700) | 2.10914391 |
| 174 | neutrophil activation (GO:0042119) | 2.09664551 |
| 175 | regulation of spindle organization (GO:0090224) | 2.09588443 |
| 176 | protein-lipid complex assembly (GO:0065005) | 2.09544026 |
| 177 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.09270979 |
| 178 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.09119101 |
| 179 | positive regulation of B cell differentiation (GO:0045579) | 2.08955667 |
| 180 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.08426176 |
| 181 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.08318737 |
| 182 | positive regulation of mast cell activation (GO:0033005) | 2.07030033 |
| 183 | granulocyte activation (GO:0036230) | 2.07025478 |
| 184 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.06965032 |
| 185 | mitotic nuclear envelope disassembly (GO:0007077) | 2.06276127 |
| 186 | lymphocyte mediated immunity (GO:0002449) | 2.05639188 |
| 187 | lipoprotein metabolic process (GO:0042157) | 2.05604043 |
| 188 | negative regulation of interleukin-12 production (GO:0032695) | 2.05196993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.03927852 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.38204357 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.70818885 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.19212370 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.99536651 |
| 6 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.79675923 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.73915680 |
| 8 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.67572608 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.63145042 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.51454968 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51258550 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.50904580 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.43813433 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.38948139 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.38525198 |
| 16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.35659064 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.21748288 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.16934027 |
| 19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.09200893 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.09075457 |
| 21 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.08070990 |
| 22 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.07979488 |
| 23 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.06562776 |
| 24 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.03920246 |
| 25 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.02985220 |
| 26 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.02136891 |
| 27 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.99751360 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.96940593 |
| 29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.96845573 |
| 30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.94166937 |
| 31 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.90682974 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.89245346 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.87490717 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84807470 |
| 35 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.84627261 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.83827070 |
| 37 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.80246623 |
| 38 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.79754524 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.76659763 |
| 40 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.75711087 |
| 41 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.75362879 |
| 42 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.75257635 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.73973826 |
| 44 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.72621644 |
| 45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68282087 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.67407259 |
| 47 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.67090741 |
| 48 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.65210477 |
| 49 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.64215377 |
| 50 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.61778939 |
| 51 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61397004 |
| 52 | MYB_26560356_Chip-Seq_TH2_Human | 1.60598194 |
| 53 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.60558745 |
| 54 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.60553565 |
| 55 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.59063698 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.58146886 |
| 57 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.54399673 |
| 58 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.52971052 |
| 59 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.52521791 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.51815816 |
| 61 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.50473986 |
| 62 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.46337987 |
| 63 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.46319897 |
| 64 | * MYC_22102868_ChIP-Seq_BL_Human | 1.45343504 |
| 65 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44796782 |
| 66 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.44481032 |
| 67 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.43775088 |
| 68 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.43717761 |
| 69 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.42070533 |
| 70 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.41355994 |
| 71 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41216913 |
| 72 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.40380917 |
| 73 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.40262392 |
| 74 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.39247943 |
| 75 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.39156918 |
| 76 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38251245 |
| 77 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.35957995 |
| 78 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.35833915 |
| 79 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.35743931 |
| 80 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.34085323 |
| 81 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33611137 |
| 82 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.30159385 |
| 83 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.29754023 |
| 84 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.28818153 |
| 85 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.27766061 |
| 86 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.26369819 |
| 87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25047919 |
| 88 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.24548160 |
| 89 | MAF_26560356_Chip-Seq_TH1_Human | 1.23322497 |
| 90 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.21993000 |
| 91 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.21693062 |
| 92 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20731661 |
| 93 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.20068463 |
| 94 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.19751936 |
| 95 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.19347084 |
| 96 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.19330642 |
| 97 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.19288580 |
| 98 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.18951773 |
| 99 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.17575865 |
| 100 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15377512 |
| 101 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14656119 |
| 102 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.14592973 |
| 103 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.13369182 |
| 104 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.13152636 |
| 105 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.12890455 |
| 106 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.12611279 |
| 107 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11932596 |
| 108 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.11538123 |
| 109 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10705892 |
| 110 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.10013226 |
| 111 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.09613087 |
| 112 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.09496512 |
| 113 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09179754 |
| 114 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07187730 |
| 115 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.07098249 |
| 116 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06661854 |
| 117 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05381986 |
| 118 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.05149389 |
| 119 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.05065907 |
| 120 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.04552645 |
| 121 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.03180898 |
| 122 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.02588298 |
| 123 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.02089843 |
| 124 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01844586 |
| 125 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.01573865 |
| 126 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.01050526 |
| 127 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.01050526 |
| 128 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00188371 |
| 129 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.00009885 |
| 130 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.97002807 |
| 131 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.96782170 |
| 132 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95242102 |
| 133 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.94848122 |
| 134 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.94666477 |
| 135 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.94326303 |
| 136 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94127504 |
| 137 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93985601 |
| 138 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.93412649 |
| 139 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93342729 |
| 140 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92411725 |
| 141 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.92082392 |
| 142 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91928927 |
| 143 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.91056131 |
| 144 | ATF3_27146783_Chip-Seq_COLON_Human | 0.90696299 |
| 145 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.90266118 |
| 146 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.89798545 |
| 147 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.87702936 |
| 148 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87341312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.09609104 |
| 2 | MP0003303_peritoneal_inflammation | 3.02869489 |
| 3 | MP0005451_abnormal_body_composition | 2.84480148 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.74762232 |
| 5 | MP0010094_abnormal_chromosome_stability | 2.70332534 |
| 6 | MP0005360_urolithiasis | 2.63983039 |
| 7 | MP0010352_gastrointestinal_tract_polyps | 2.49202749 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 2.45392481 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.37248467 |
| 10 | MP0003693_abnormal_embryo_hatching | 2.27431249 |
| 11 | MP0008932_abnormal_embryonic_tissue | 2.24255940 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.19873159 |
| 13 | MP0009840_abnormal_foam_cell | 2.18208898 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.13482516 |
| 15 | MP0002419_abnormal_innate_immunity | 2.12353373 |
| 16 | MP0008260_abnormal_autophagy | 2.04503066 |
| 17 | MP0001730_embryonic_growth_arrest | 2.02311336 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 1.97001650 |
| 19 | MP0005000_abnormal_immune_tolerance | 1.93825932 |
| 20 | MP0000350_abnormal_cell_proliferation | 1.92501470 |
| 21 | MP0008438_abnormal_cutaneous_collagen | 1.88871633 |
| 22 | MP0005464_abnormal_platelet_physiology | 1.87064013 |
| 23 | MP0009785_altered_susceptibility_to | 1.86341513 |
| 24 | MP0005085_abnormal_gallbladder_physiolo | 1.85829700 |
| 25 | MP0002452_abnormal_antigen_presenting | 1.79801123 |
| 26 | MP0005365_abnormal_bile_salt | 1.75142694 |
| 27 | MP0006082_CNS_inflammation | 1.73443699 |
| 28 | MP0001800_abnormal_humoral_immune | 1.72214342 |
| 29 | MP0005025_abnormal_response_to | 1.70243580 |
| 30 | MP0005076_abnormal_cell_differentiation | 1.69822002 |
| 31 | MP0005501_abnormal_skin_physiology | 1.65410047 |
| 32 | MP0003221_abnormal_cardiomyocyte_apopto | 1.63398509 |
| 33 | MP0005387_immune_system_phenotype | 1.62792998 |
| 34 | MP0001790_abnormal_immune_system | 1.62792998 |
| 35 | MP0002796_impaired_skin_barrier | 1.62153022 |
| 36 | MP0000685_abnormal_immune_system | 1.61653719 |
| 37 | MP0004185_abnormal_adipocyte_glucose | 1.61462589 |
| 38 | MP0003941_abnormal_skin_development | 1.61041415 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.60518716 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.59731842 |
| 41 | MP0004233_abnormal_muscle_weight | 1.58471318 |
| 42 | MP0005257_abnormal_intraocular_pressure | 1.58070219 |
| 43 | MP0002723_abnormal_immune_serum | 1.57776763 |
| 44 | MP0002396_abnormal_hematopoietic_system | 1.57415740 |
| 45 | MP0010307_abnormal_tumor_latency | 1.53411721 |
| 46 | MP0000490_abnormal_crypts_of | 1.52426479 |
| 47 | MP0010155_abnormal_intestine_physiology | 1.51947615 |
| 48 | MP0003566_abnormal_cell_adhesion | 1.51524313 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.51286752 |
| 50 | MP0003806_abnormal_nucleotide_metabolis | 1.50741351 |
| 51 | MP0003252_abnormal_bile_duct | 1.49251548 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.49104815 |
| 53 | MP0001819_abnormal_immune_cell | 1.48485859 |
| 54 | MP0003724_increased_susceptibility_to | 1.48462090 |
| 55 | MP0002420_abnormal_adaptive_immunity | 1.47919725 |
| 56 | MP0003186_abnormal_redox_activity | 1.45627547 |
| 57 | MP0001853_heart_inflammation | 1.43798359 |
| 58 | MP0006054_spinal_hemorrhage | 1.41982892 |
| 59 | MP0002080_prenatal_lethality | 1.41535162 |
| 60 | MP0001672_abnormal_embryogenesis/_devel | 1.40538858 |
| 61 | MP0005380_embryogenesis_phenotype | 1.40538858 |
| 62 | MP0004947_skin_inflammation | 1.40023435 |
| 63 | MP0002405_respiratory_system_inflammati | 1.38725360 |
| 64 | MP0005623_abnormal_meninges_morphology | 1.38521086 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 1.38095531 |
| 66 | MP0002166_altered_tumor_susceptibility | 1.37243671 |
| 67 | MP0005671_abnormal_response_to | 1.36645101 |
| 68 | MP0001666_abnormal_nutrient_absorption | 1.36426261 |
| 69 | MP0009333_abnormal_splenocyte_physiolog | 1.35672411 |
| 70 | MP0008469_abnormal_protein_level | 1.34841794 |
| 71 | MP0001697_abnormal_embryo_size | 1.33608605 |
| 72 | MP0005621_abnormal_cell_physiology | 1.32722126 |
| 73 | MP0002254_reproductive_system_inflammat | 1.32309107 |
| 74 | MP0003984_embryonic_growth_retardation | 1.32276909 |
| 75 | MP0003453_abnormal_keratinocyte_physiol | 1.31796201 |
| 76 | MP0003172_abnormal_lysosome_physiology | 1.30083065 |
| 77 | MP0008058_abnormal_DNA_repair | 1.29736891 |
| 78 | MP0000609_abnormal_liver_physiology | 1.29584999 |
| 79 | MP0004272_abnormal_basement_membrane | 1.29101796 |
| 80 | MP0000313_abnormal_cell_death | 1.27032816 |
| 81 | MP0002006_tumorigenesis | 1.25722178 |
| 82 | MP0002088_abnormal_embryonic_growth/wei | 1.24133340 |
| 83 | MP0003763_abnormal_thymus_physiology | 1.21502784 |
| 84 | MP0000858_altered_metastatic_potential | 1.21164068 |
| 85 | MP0001727_abnormal_embryo_implantation | 1.20607987 |
| 86 | MP0000358_abnormal_cell_content/ | 1.20243734 |
| 87 | MP0002398_abnormal_bone_marrow | 1.20194529 |
| 88 | MP0002060_abnormal_skin_morphology | 1.18128352 |
| 89 | MP0002086_abnormal_extraembryonic_tissu | 1.17724529 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 1.17551794 |
| 91 | MP0010329_abnormal_lipoprotein_level | 1.17115792 |
| 92 | MP0000689_abnormal_spleen_morphology | 1.16777933 |
| 93 | MP0000716_abnormal_immune_system | 1.16314347 |
| 94 | MP0009764_decreased_sensitivity_to | 1.16141758 |
| 95 | MP0005384_cellular_phenotype | 1.14501143 |
| 96 | MP0003183_abnormal_peptide_metabolism | 1.14305268 |
| 97 | MP0001216_abnormal_epidermal_layer | 1.12617802 |
| 98 | MP0001849_ear_inflammation | 1.11468600 |
| 99 | MP0001542_abnormal_bone_strength | 1.11414026 |
| 100 | MP0002722_abnormal_immune_system | 1.10429025 |
| 101 | MP0008875_abnormal_xenobiotic_pharmacok | 1.09910448 |
| 102 | MP0005397_hematopoietic_system_phenotyp | 1.09645941 |
| 103 | MP0001545_abnormal_hematopoietic_system | 1.09645941 |
| 104 | MP0002877_abnormal_melanocyte_morpholog | 1.09318533 |
| 105 | MP0004782_abnormal_surfactant_physiolog | 1.07150733 |
| 106 | MP0004808_abnormal_hematopoietic_stem | 1.05769365 |
| 107 | MP0002429_abnormal_blood_cell | 1.02698489 |
| 108 | MP0003786_premature_aging | 1.02099618 |
| 109 | MP0005319_abnormal_enzyme/_coenzyme | 1.02022527 |
| 110 | MP0001873_stomach_inflammation | 1.00707530 |
| 111 | MP0009697_abnormal_copulation | 0.99441646 |
| 112 | MP0004957_abnormal_blastocyst_morpholog | 0.99150298 |
| 113 | MP0000598_abnormal_liver_morphology | 0.98779240 |
| 114 | MP0001881_abnormal_mammary_gland | 0.98658760 |
| 115 | MP0002019_abnormal_tumor_incidence | 0.98557361 |
| 116 | MP0002998_abnormal_bone_remodeling | 0.97711319 |
| 117 | MP0009763_increased_sensitivity_to | 0.97137800 |
| 118 | MP0005023_abnormal_wound_healing | 0.96526353 |
| 119 | MP0000604_amyloidosis | 0.95626255 |
| 120 | MP0003091_abnormal_cell_migration | 0.95263714 |
| 121 | MP0004197_abnormal_fetal_growth/weight/ | 0.94650507 |
| 122 | MP0003448_altered_tumor_morphology | 0.93614074 |
| 123 | MP0008007_abnormal_cellular_replicative | 0.93153198 |
| 124 | MP0000627_abnormal_mammary_gland | 0.93022427 |
| 125 | MP0004264_abnormal_extraembryonic_tissu | 0.92857103 |
| 126 | MP0002085_abnormal_embryonic_tissue | 0.91555317 |
| 127 | MP0010234_abnormal_vibrissa_follicle | 0.91526388 |
| 128 | MP0001243_abnormal_dermal_layer | 0.90436681 |
| 129 | MP0008057_abnormal_DNA_replication | 0.89905328 |
| 130 | MP0009053_abnormal_anal_canal | 0.89882263 |
| 131 | MP0000343_altered_response_to | 0.88927603 |
| 132 | MP0000537_abnormal_urethra_morphology | 0.88004549 |
| 133 | MP0003077_abnormal_cell_cycle | 0.87308672 |
| 134 | MP0009672_abnormal_birth_weight | 0.86109544 |
| 135 | MP0002084_abnormal_developmental_patter | 0.85581900 |
| 136 | MP0005166_decreased_susceptibility_to | 0.84124445 |
| 137 | MP0002009_preneoplasia | 0.83933287 |
| 138 | MP0006035_abnormal_mitochondrial_morpho | 0.83699435 |
| 139 | MP0004510_myositis | 0.83523366 |
| 140 | MP0005310_abnormal_salivary_gland | 0.82883000 |
| 141 | MP0009643_abnormal_urine_homeostasis | 0.82471911 |
| 142 | MP0001915_intracranial_hemorrhage | 0.81832747 |
| 143 | MP0003795_abnormal_bone_structure | 0.80384122 |
| 144 | MP0003111_abnormal_nucleus_morphology | 0.80099030 |
| 145 | MP0005332_abnormal_amino_acid | 0.80019603 |
| 146 | MP0000703_abnormal_thymus_morphology | 0.78714658 |
| 147 | MP0005390_skeleton_phenotype | 0.78425671 |
| 148 | MP0003075_altered_response_to | 0.77538224 |
| 149 | MP0005083_abnormal_biliary_tract | 0.76653022 |
| 150 | MP0000733_abnormal_muscle_development | 0.75127661 |
| 151 | MP0005408_hypopigmentation | 0.73935320 |
| 152 | MP0001661_extended_life_span | 0.70897782 |
| 153 | MP0003315_abnormal_perineum_morphology | 0.70007735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.21720316 |
| 2 | Recurrent abscess formation (HP:0002722) | 3.80560207 |
| 3 | Eczematoid dermatitis (HP:0000976) | 3.77307856 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 3.68866448 |
| 5 | Premature rupture of membranes (HP:0001788) | 3.45385514 |
| 6 | Myocardial infarction (HP:0001658) | 3.42795507 |
| 7 | Termporal pattern (HP:0011008) | 3.32894905 |
| 8 | Insidious onset (HP:0003587) | 3.32894905 |
| 9 | Microvesicular hepatic steatosis (HP:0001414) | 3.16933069 |
| 10 | Selective tooth agenesis (HP:0001592) | 3.07534369 |
| 11 | Mucopolysacchariduria (HP:0008155) | 2.98522969 |
| 12 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.98522969 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 2.91070165 |
| 14 | Cortical dysplasia (HP:0002539) | 2.89253767 |
| 15 | Vacuolated lymphocytes (HP:0001922) | 2.86660322 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 2.85132522 |
| 17 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.84897986 |
| 18 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.84897986 |
| 19 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.84897986 |
| 20 | Vertebral compression fractures (HP:0002953) | 2.84549700 |
| 21 | Progressive external ophthalmoplegia (HP:0000590) | 2.83641152 |
| 22 | Progressive muscle weakness (HP:0003323) | 2.76887558 |
| 23 | Abnormality of macrophages (HP:0004311) | 2.74842575 |
| 24 | Autoimmune thrombocytopenia (HP:0001973) | 2.74319962 |
| 25 | Xanthomatosis (HP:0000991) | 2.74193800 |
| 26 | Hematochezia (HP:0002573) | 2.72898976 |
| 27 | Hydroxyprolinuria (HP:0003080) | 2.68825342 |
| 28 | Abnormality of proline metabolism (HP:0010907) | 2.68825342 |
| 29 | Rough bone trabeculation (HP:0100670) | 2.68489449 |
| 30 | Dysostosis multiplex (HP:0000943) | 2.66393082 |
| 31 | Shoulder girdle muscle weakness (HP:0003547) | 2.64993352 |
| 32 | Upper limb muscle weakness (HP:0003484) | 2.64841393 |
| 33 | Recurrent fungal infections (HP:0002841) | 2.63642414 |
| 34 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.58129460 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.51957895 |
| 36 | Deviation of the thumb (HP:0009603) | 2.47507390 |
| 37 | Achilles tendon contracture (HP:0001771) | 2.47026160 |
| 38 | Back pain (HP:0003418) | 2.46664860 |
| 39 | Abnormality of the common coagulation pathway (HP:0010990) | 2.46127282 |
| 40 | Abnormality of the intrinsic pathway (HP:0010989) | 2.46025653 |
| 41 | Recurrent viral infections (HP:0004429) | 2.45377415 |
| 42 | Osteolytic defects of the hand bones (HP:0009699) | 2.39753686 |
| 43 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.39753686 |
| 44 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.36540548 |
| 45 | Myositis (HP:0100614) | 2.36386885 |
| 46 | Proximal placement of thumb (HP:0009623) | 2.34412279 |
| 47 | Glomerulonephritis (HP:0000099) | 2.34095127 |
| 48 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.34094267 |
| 49 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.34094267 |
| 50 | Periodontitis (HP:0000704) | 2.32858374 |
| 51 | Recurrent skin infections (HP:0001581) | 2.31541948 |
| 52 | Hypoalphalipoproteinemia (HP:0003233) | 2.30608989 |
| 53 | Thrombocytosis (HP:0001894) | 2.28538693 |
| 54 | Abnormality of glycolipid metabolism (HP:0010969) | 2.25895735 |
| 55 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.25895735 |
| 56 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.25895735 |
| 57 | Distal lower limb amyotrophy (HP:0008944) | 2.25092982 |
| 58 | Abnormal trabecular bone morphology (HP:0100671) | 2.24423676 |
| 59 | Tetraparesis (HP:0002273) | 2.24244620 |
| 60 | Gingivitis (HP:0000230) | 2.24003451 |
| 61 | Hypobetalipoproteinemia (HP:0003563) | 2.23388960 |
| 62 | Hypolipoproteinemia (HP:0010981) | 2.23268474 |
| 63 | Spinal cord lesions (HP:0100561) | 2.22730092 |
| 64 | Syringomyelia (HP:0003396) | 2.22730092 |
| 65 | Abnormality of complement system (HP:0005339) | 2.22715481 |
| 66 | Abnormality of the lumbar spine (HP:0100712) | 2.21023160 |
| 67 | Trismus (HP:0000211) | 2.20995194 |
| 68 | Abnormality of oral frenula (HP:0000190) | 2.20768926 |
| 69 | Ragged-red muscle fibers (HP:0003200) | 2.20084131 |
| 70 | Complement deficiency (HP:0004431) | 2.19931646 |
| 71 | Pustule (HP:0200039) | 2.18560277 |
| 72 | Abnormality of the umbilical cord (HP:0010881) | 2.17695338 |
| 73 | Basal ganglia calcification (HP:0002135) | 2.17670319 |
| 74 | Nausea (HP:0002018) | 2.17299261 |
| 75 | Multiple enchondromatosis (HP:0005701) | 2.17287784 |
| 76 | Mediastinal lymphadenopathy (HP:0100721) | 2.16945471 |
| 77 | Interstitial pulmonary disease (HP:0006530) | 2.15400632 |
| 78 | Protrusio acetabuli (HP:0003179) | 2.13445907 |
| 79 | Hypoglycemic coma (HP:0001325) | 2.12805534 |
| 80 | Fatigue (HP:0012378) | 2.12217513 |
| 81 | Disinhibition (HP:0000734) | 2.11488642 |
| 82 | Ankyloglossia (HP:0010296) | 2.11273484 |
| 83 | Micronodular cirrhosis (HP:0001413) | 2.09424314 |
| 84 | Hyperacusis (HP:0010780) | 2.09206977 |
| 85 | Biconcave vertebral bodies (HP:0004586) | 2.08629305 |
| 86 | Petechiae (HP:0000967) | 2.07908548 |
| 87 | Cervical subluxation (HP:0003308) | 2.07498964 |
| 88 | Intrahepatic cholestasis (HP:0001406) | 2.07491355 |
| 89 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.06876807 |
| 90 | Abnormality of the Achilles tendon (HP:0005109) | 2.06762031 |
| 91 | Limb-girdle muscle atrophy (HP:0003797) | 2.05008866 |
| 92 | Ankle contracture (HP:0006466) | 2.03674489 |
| 93 | Epidermoid cyst (HP:0200040) | 2.03364652 |
| 94 | Orthostatic hypotension (HP:0001278) | 2.02201417 |
| 95 | Esophageal varix (HP:0002040) | 2.02034191 |
| 96 | Short nail (HP:0001799) | 2.01105030 |
| 97 | Chronic diarrhea (HP:0002028) | 2.00723600 |
| 98 | Upper motor neuron abnormality (HP:0002127) | 1.99002395 |
| 99 | Progressive hearing impairment (HP:0001730) | 1.98857025 |
| 100 | Deep venous thrombosis (HP:0002625) | 1.98283163 |
| 101 | Arterial thrombosis (HP:0004420) | 1.97918238 |
| 102 | IgA deficiency (HP:0002720) | 1.97093705 |
| 103 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.94912050 |
| 104 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.94241389 |
| 105 | Insomnia (HP:0100785) | 1.93550058 |
| 106 | Abnormality of glycolysis (HP:0004366) | 1.93467494 |
| 107 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.92596148 |
| 108 | Single umbilical artery (HP:0001195) | 1.92596148 |
| 109 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.92596148 |
| 110 | Deep philtrum (HP:0002002) | 1.92559916 |
| 111 | Long palpebral fissure (HP:0000637) | 1.92098504 |
| 112 | Increased serum pyruvate (HP:0003542) | 1.91762622 |
| 113 | Gingival bleeding (HP:0000225) | 1.91193778 |
| 114 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.90949527 |
| 115 | Spastic diplegia (HP:0001264) | 1.88917968 |
| 116 | Hepatocellular carcinoma (HP:0001402) | 1.87048017 |
| 117 | Orchitis (HP:0100796) | 1.86913764 |
| 118 | Premature loss of primary teeth (HP:0006323) | 1.86398658 |
| 119 | Urticaria (HP:0001025) | 1.86019313 |
| 120 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.84750142 |
| 121 | Pelvic girdle muscle weakness (HP:0003749) | 1.84710771 |
| 122 | Anorexia (HP:0002039) | 1.84112934 |
| 123 | Abnormal platelet function (HP:0011869) | 1.83006702 |
| 124 | Impaired platelet aggregation (HP:0003540) | 1.83006702 |
| 125 | Abnormality of T cell physiology (HP:0011840) | 1.82427960 |
| 126 | Nonimmune hydrops fetalis (HP:0001790) | 1.81794008 |
| 127 | Abnormality of purine metabolism (HP:0004352) | 1.81374274 |
| 128 | Reduced antithrombin III activity (HP:0001976) | 1.80577517 |
| 129 | Abnormality of iron homeostasis (HP:0011031) | 1.80433663 |
| 130 | Poor head control (HP:0002421) | 1.80368012 |
| 131 | Coxa valga (HP:0002673) | 1.80325486 |
| 132 | Hyperammonemia (HP:0001987) | 1.79410297 |
| 133 | Rectal prolapse (HP:0002035) | 1.79377305 |
| 134 | Onycholysis (HP:0001806) | 1.78753933 |
| 135 | Abnormal foot bone ossification (HP:0010675) | 1.78511756 |
| 136 | Abnormal platelet volume (HP:0011876) | 1.78037081 |
| 137 | Cellulitis (HP:0100658) | 1.77381243 |
| 138 | Degeneration of anterior horn cells (HP:0002398) | 1.76510022 |
| 139 | Abnormality of the anterior horn cell (HP:0006802) | 1.76510022 |
| 140 | Pathologic fracture (HP:0002756) | 1.76369778 |
| 141 | Microretrognathia (HP:0000308) | 1.75870842 |
| 142 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.75714628 |
| 143 | Thrombophlebitis (HP:0004418) | 1.75286561 |
| 144 | Osteomyelitis (HP:0002754) | 1.75267735 |
| 145 | Entropion (HP:0000621) | 1.74852735 |
| 146 | Increased density of long bones (HP:0006392) | 1.74399526 |
| 147 | Mitral stenosis (HP:0001718) | 1.73674202 |
| 148 | Overlapping toe (HP:0001845) | 1.72738533 |
| 149 | Subacute progressive viral hepatitis (HP:0006572) | 1.72708038 |
| 150 | IgM deficiency (HP:0002850) | 1.72607023 |
| 151 | Atrophic scars (HP:0001075) | 1.72570801 |
| 152 | Poikiloderma (HP:0001029) | 1.72568145 |
| 153 | Secondary amenorrhea (HP:0000869) | 1.72300555 |
| 154 | Hepatosplenomegaly (HP:0001433) | 1.72258895 |
| 155 | Abnormality of the prostate (HP:0008775) | 1.72058316 |
| 156 | Beaking of vertebral bodies (HP:0004568) | 1.71430612 |
| 157 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.71243196 |
| 158 | Global brain atrophy (HP:0002283) | 1.71129491 |
| 159 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.71116913 |
| 160 | Increased mean platelet volume (HP:0011877) | 1.71068306 |
| 161 | Squamous cell carcinoma (HP:0002860) | 1.69128343 |
| 162 | Sparse lateral eyebrow (HP:0005338) | 1.68872090 |
| 163 | Increased nuchal translucency (HP:0010880) | 1.68510084 |
| 164 | Breech presentation (HP:0001623) | 1.68503430 |
| 165 | Lower limb hyperreflexia (HP:0002395) | 1.67907217 |
| 166 | Autoamputation (HP:0001218) | 1.65748988 |
| 167 | Chromsome breakage (HP:0040012) | 1.65287233 |
| 168 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.65100957 |
| 169 | Upper limb amyotrophy (HP:0009129) | 1.65057037 |
| 170 | Distal upper limb amyotrophy (HP:0007149) | 1.65057037 |
| 171 | Premature ovarian failure (HP:0008209) | 1.63405476 |
| 172 | Hand muscle atrophy (HP:0009130) | 1.61920776 |
| 173 | Leiomyosarcoma (HP:0100243) | 1.58803149 |
| 174 | Uterine leiomyosarcoma (HP:0002891) | 1.58803149 |
| 175 | Fasciculations (HP:0002380) | 1.57111728 |
| 176 | Overriding aorta (HP:0002623) | 1.56408649 |
| 177 | Medulloblastoma (HP:0002885) | 1.55814572 |
| 178 | Lower limb amyotrophy (HP:0007210) | 1.55429729 |
| 179 | Bone pain (HP:0002653) | 1.54882672 |
| 180 | Generalized amyotrophy (HP:0003700) | 1.53169602 |
| 181 | Gastrointestinal stroma tumor (HP:0100723) | 1.52867326 |
| 182 | Spinal rigidity (HP:0003306) | 1.52289968 |
| 183 | Cutaneous melanoma (HP:0012056) | 1.51986391 |
| 184 | Elbow flexion contracture (HP:0002987) | 1.51475371 |
| 185 | Relative macrocephaly (HP:0004482) | 1.50607862 |
| 186 | Hypergonadotropic hypogonadism (HP:0000815) | 1.50245990 |
| 187 | Hypertensive crisis (HP:0100735) | 1.49115370 |
| 188 | Flat acetabular roof (HP:0003180) | 1.49040012 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SRPK1 | 2.91485437 |
| 2 | FRK | 2.84908836 |
| 3 | PRPF4B | 2.57317412 |
| 4 | ERN1 | 2.47687405 |
| 5 | RPS6KA4 | 2.41158923 |
| 6 | NEK9 | 2.35447760 |
| 7 | TYK2 | 2.34837607 |
| 8 | SCYL2 | 2.19175349 |
| 9 | PBK | 2.09981743 |
| 10 | EIF2AK1 | 2.03445601 |
| 11 | ARAF | 1.97105129 |
| 12 | TBK1 | 1.95044647 |
| 13 | IRAK3 | 1.89480206 |
| 14 | SMG1 | 1.87524603 |
| 15 | ACVR1B | 1.86891193 |
| 16 | TSSK6 | 1.84316340 |
| 17 | CDK12 | 1.81945199 |
| 18 | NEK2 | 1.79633830 |
| 19 | MAP3K14 | 1.78767310 |
| 20 | ERBB3 | 1.75762556 |
| 21 | STK3 | 1.70684510 |
| 22 | JAK3 | 1.70385883 |
| 23 | PKN2 | 1.70039597 |
| 24 | NUAK1 | 1.61647597 |
| 25 | LATS1 | 1.59477168 |
| 26 | BRSK2 | 1.59474340 |
| 27 | BLK | 1.56530244 |
| 28 | PLK4 | 1.55959940 |
| 29 | NME2 | 1.53791788 |
| 30 | STK10 | 1.53217942 |
| 31 | TRIB3 | 1.53076315 |
| 32 | EIF2AK3 | 1.50853602 |
| 33 | WEE1 | 1.49625315 |
| 34 | NEK1 | 1.47747288 |
| 35 | DYRK3 | 1.45888176 |
| 36 | FGFR3 | 1.43906289 |
| 37 | RIPK4 | 1.42662081 |
| 38 | SIK3 | 1.38081731 |
| 39 | MAP3K10 | 1.37134117 |
| 40 | LATS2 | 1.36516947 |
| 41 | FLT3 | 1.33767324 |
| 42 | IRAK4 | 1.32614996 |
| 43 | CDK6 | 1.31580578 |
| 44 | TAOK2 | 1.30438131 |
| 45 | JAK1 | 1.30401977 |
| 46 | KSR2 | 1.26931622 |
| 47 | TEC | 1.26495447 |
| 48 | MAP4K1 | 1.26324404 |
| 49 | KIT | 1.22559995 |
| 50 | ERBB4 | 1.21448992 |
| 51 | MOS | 1.21291882 |
| 52 | MARK3 | 1.21096584 |
| 53 | STK4 | 1.21042858 |
| 54 | MST4 | 1.18696997 |
| 55 | MAP3K13 | 1.15112993 |
| 56 | PIM2 | 1.13355451 |
| 57 | BCR | 1.10158794 |
| 58 | PIM1 | 1.04238463 |
| 59 | LRRK2 | 1.02380996 |
| 60 | TRPM7 | 0.99690572 |
| 61 | PTK6 | 0.99310676 |
| 62 | CSK | 0.97708384 |
| 63 | IKBKB | 0.97527979 |
| 64 | IKBKE | 0.97336399 |
| 65 | PDK2 | 0.96099670 |
| 66 | CDK7 | 0.94416923 |
| 67 | ZAK | 0.94029663 |
| 68 | DMPK | 0.93785815 |
| 69 | CLK1 | 0.89448341 |
| 70 | PAK4 | 0.89296882 |
| 71 | PDGFRA | 0.88967398 |
| 72 | FGFR4 | 0.88907112 |
| 73 | ZAP70 | 0.87655856 |
| 74 | JAK2 | 0.87503647 |
| 75 | BUB1 | 0.87015257 |
| 76 | BRAF | 0.86053366 |
| 77 | CDK4 | 0.85120947 |
| 78 | MAP3K3 | 0.85061439 |
| 79 | CDC7 | 0.84863399 |
| 80 | AURKA | 0.83379133 |
| 81 | EPHA2 | 0.83375613 |
| 82 | ICK | 0.83092375 |
| 83 | RAF1 | 0.82577754 |
| 84 | MAP2K3 | 0.81502964 |
| 85 | CHUK | 0.81419377 |
| 86 | TESK1 | 0.80865892 |
| 87 | NLK | 0.80583094 |
| 88 | CSF1R | 0.80410814 |
| 89 | TESK2 | 0.80134504 |
| 90 | ABL2 | 0.80027732 |
| 91 | MAP3K8 | 0.79633341 |
| 92 | TGFBR2 | 0.79393274 |
| 93 | LIMK1 | 0.77761964 |
| 94 | ALK | 0.77352314 |
| 95 | BTK | 0.75959524 |
| 96 | MAP3K5 | 0.75378831 |
| 97 | SYK | 0.74902081 |
| 98 | PLK1 | 0.73191298 |
| 99 | BRD4 | 0.71754853 |
| 100 | IRAK2 | 0.71746379 |
| 101 | MATK | 0.71537330 |
| 102 | EPHA3 | 0.70493195 |
| 103 | HCK | 0.69845190 |
| 104 | EEF2K | 0.69453411 |
| 105 | KSR1 | 0.69159954 |
| 106 | KDR | 0.68956961 |
| 107 | CHEK1 | 0.67804404 |
| 108 | CHEK2 | 0.67320069 |
| 109 | GRK6 | 0.66891085 |
| 110 | BMPR2 | 0.64936992 |
| 111 | STK24 | 0.64246658 |
| 112 | LYN | 0.64095175 |
| 113 | PTK2 | 0.61829269 |
| 114 | NTRK1 | 0.61362975 |
| 115 | PIK3CG | 0.61337750 |
| 116 | SIK1 | 0.61173993 |
| 117 | CDK8 | 0.61067160 |
| 118 | STK16 | 0.59575073 |
| 119 | MET | 0.59153507 |
| 120 | VRK1 | 0.59056454 |
| 121 | TTN | 0.58165590 |
| 122 | MAP3K11 | 0.57803746 |
| 123 | ITK | 0.57737694 |
| 124 | CDK9 | 0.57716632 |
| 125 | AURKB | 0.57554095 |
| 126 | BRSK1 | 0.57230901 |
| 127 | IRAK1 | 0.56628332 |
| 128 | TAOK3 | 0.54717562 |
| 129 | CDK14 | 0.53738791 |
| 130 | EPHB1 | 0.53644122 |
| 131 | ATR | 0.53512551 |
| 132 | CAMKK2 | 0.51356648 |
| 133 | CAMK1D | 0.51314464 |
| 134 | EIF2AK2 | 0.50447817 |
| 135 | PIK3CA | 0.49076397 |
| 136 | MAPKAPK2 | 0.48760712 |
| 137 | MST1R | 0.48359333 |
| 138 | TTK | 0.47446751 |
| 139 | CDK18 | 0.46166380 |
| 140 | CDK11A | 0.45617963 |
| 141 | RPS6KA5 | 0.45523180 |
| 142 | ABL1 | 0.45326644 |
| 143 | PLK3 | 0.44585549 |
| 144 | MKNK1 | 0.44552057 |
| 145 | CDK15 | 0.43880703 |
| 146 | PAK1 | 0.43352234 |
| 147 | PAK2 | 0.41028822 |
| 148 | MAP3K9 | 0.39955354 |
| 149 | CSNK1A1L | 0.37864368 |
| 150 | RPS6KB2 | 0.37807867 |
| 151 | VRK2 | 0.37436460 |
| 152 | CSNK1G3 | 0.35998294 |
| 153 | MTOR | 0.35631719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 2.45002264 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.43837895 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 2.43127956 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.38087660 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.15146738 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 2.09447321 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.06415867 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.02886366 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.02012150 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.97252559 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.86332324 |
| 12 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.84659934 |
| 13 | RNA transport_Homo sapiens_hsa03013 | 1.81505010 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.80156760 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.78785243 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.74348681 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.72431394 |
| 18 | Thyroid cancer_Homo sapiens_hsa05216 | 1.62741232 |
| 19 | Lysosome_Homo sapiens_hsa04142 | 1.60578901 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.59274930 |
| 21 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.57401491 |
| 22 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.55731908 |
| 23 | Bladder cancer_Homo sapiens_hsa05219 | 1.54152964 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.52807304 |
| 25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52737457 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.51864208 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.44006178 |
| 28 | Sulfur relay system_Homo sapiens_hsa04122 | 1.43592619 |
| 29 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.42628955 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.40925834 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.39859120 |
| 32 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.36319828 |
| 33 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.34848763 |
| 34 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.34238883 |
| 35 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.32651445 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32550288 |
| 37 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.27275760 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.26652785 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.26334695 |
| 40 | Pertussis_Homo sapiens_hsa05133 | 1.25595508 |
| 41 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.23637669 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23333436 |
| 43 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.20632529 |
| 44 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.20263665 |
| 45 | DNA replication_Homo sapiens_hsa03030 | 1.20019740 |
| 46 | Measles_Homo sapiens_hsa05162 | 1.19115493 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18925989 |
| 48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.18467826 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.18312876 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 1.17670904 |
| 51 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.14655974 |
| 52 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.11334493 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 1.10699943 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.09651130 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.08202706 |
| 56 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.07912548 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 1.04798292 |
| 58 | Malaria_Homo sapiens_hsa05144 | 1.04154108 |
| 59 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.02645613 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 1.01986703 |
| 61 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.00024351 |
| 62 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96960160 |
| 63 | Cell cycle_Homo sapiens_hsa04110 | 0.94185052 |
| 64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94036886 |
| 65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.93789363 |
| 66 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.93521142 |
| 67 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.93492010 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92377310 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.91180933 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.90611956 |
| 71 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.89951962 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.87378168 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.85310153 |
| 74 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84823498 |
| 75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84755746 |
| 76 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.84531399 |
| 77 | HTLV-I infection_Homo sapiens_hsa05166 | 0.84393771 |
| 78 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.84111401 |
| 79 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.84053187 |
| 80 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.82360295 |
| 81 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.82126193 |
| 82 | Adherens junction_Homo sapiens_hsa04520 | 0.81053628 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.80721499 |
| 84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80702760 |
| 85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78226234 |
| 86 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.78048793 |
| 87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77775995 |
| 88 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.76542121 |
| 89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76457975 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74859737 |
| 91 | RNA polymerase_Homo sapiens_hsa03020 | 0.74853405 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74711450 |
| 93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74634467 |
| 94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73265131 |
| 95 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.72602418 |
| 96 | Protein export_Homo sapiens_hsa03060 | 0.72023087 |
| 97 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.70002355 |
| 98 | Salmonella infection_Homo sapiens_hsa05132 | 0.69774095 |
| 99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69295883 |
| 100 | Homologous recombination_Homo sapiens_hsa03440 | 0.69258902 |
| 101 | Peroxisome_Homo sapiens_hsa04146 | 0.67833475 |
| 102 | Prostate cancer_Homo sapiens_hsa05215 | 0.67476631 |
| 103 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.67159022 |
| 104 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.67154934 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66326703 |
| 106 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66195497 |
| 107 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64999331 |
| 108 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64793184 |
| 109 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64415586 |
| 110 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.62905137 |
| 111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.62238069 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.61320384 |
| 113 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.59694052 |
| 114 | Hepatitis C_Homo sapiens_hsa05160 | 0.58201666 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57413011 |
| 116 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.57275476 |
| 117 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.56440947 |
| 118 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.56339989 |
| 119 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55403459 |
| 120 | Ribosome_Homo sapiens_hsa03010 | 0.55372180 |
| 121 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.53964239 |
| 122 | Platelet activation_Homo sapiens_hsa04611 | 0.53908364 |
| 123 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51784167 |
| 124 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.51680900 |
| 125 | Mineral absorption_Homo sapiens_hsa04978 | 0.49770699 |
| 126 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49394100 |
| 127 | RNA degradation_Homo sapiens_hsa03018 | 0.49031023 |
| 128 | Prion diseases_Homo sapiens_hsa05020 | 0.48898380 |
| 129 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48672855 |
| 130 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.48372454 |
| 131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47407263 |
| 132 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.47098706 |
| 133 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.46596241 |
| 134 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46290430 |
| 135 | Histidine metabolism_Homo sapiens_hsa00340 | 0.46160748 |
| 136 | Base excision repair_Homo sapiens_hsa03410 | 0.45945394 |
| 137 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.45694628 |
| 138 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.45467344 |
| 139 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.44223118 |
| 140 | Purine metabolism_Homo sapiens_hsa00230 | 0.43741441 |
| 141 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.43488383 |
| 142 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.43232932 |
| 143 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.42824520 |
| 144 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40547741 |
| 145 | Basal transcription factors_Homo sapiens_hsa03022 | 0.39753365 |
| 146 | Endocytosis_Homo sapiens_hsa04144 | 0.39183635 |

